论文部分内容阅读
艾滋病抗病毒治疗即预防(TasP)措施,是指使用艾滋病抗病毒治疗(ART)的方法降低艾滋病病毒(HIV)传播的风险。ART通过降低HIV感染者病毒载量至检测不到的水平,从而减少个人艾滋病传播的风险。截至2013年底,全球有3500万人感染HIV,近1300万人接受ART并逐年增加。国际上已开始相关TasP卫生经济学评价,但国内相关研究较少。现就当前国内外通过利用卫生经济学的方法开展的TasP有关研究进行综述,包括卫生经济学评价要点、方法,以及当前的进展和未来展望,为改进我国现有TasP服务质量,提高ART覆盖率,加强艾滋病的预防与控制,提供科学的理论依据。
The AIDS Antiviral Therapy-Prevention (TasP) measure refers to the use of AIDS ART to reduce the risk of transmission of HIV. ART reduces the risk of individual HIV transmission by reducing the viral load of HIV-infected people to undetectable levels. As of the end of 2013, 35 million people were infected with HIV globally and nearly 13 million were receiving ART and increasing year by year. Relevant TasP health economics evaluation has begun to be carried out in the world, but there are few related research in China. Nowadays, we summarize the current TasP research conducted at home and abroad by using the method of health economics, including the key points and methods of health economics evaluation, as well as the current progress and future prospects. In order to improve the quality of our existing TasP service and increase the ART coverage rate , Strengthen AIDS prevention and control, provide a scientific theoretical basis.